Neptune Announces Research Collaboration with Nestlé
Thursday, July 12 2007

Neptune Announces Research Collaboration with Nestlé

Laval Quebec CANADA, July 12, 2007 - Neptune Technologies & Bioressources Inc. (Neptune) (NTB – TSX) is pleased to announce a collaboration with the Nestlé Research Center.

According to the signed agreement terms, Neptune and Nestlé will jointly research the effects of Neptune Krill Oil (NKO™) on exceptionally prevalent conditions affecting the worldwide adult population. The research was initiated at the beginning of July 2007. The design and identification of primary investigators for the study has been completed. Upon successful completion of the trial the companies will proceed with the Development and License Agreement.

“I am extremely pleased for this cooperation between Neptune and Nestlé. With this collaboration, we are not only fulfilling a pivotal milestone we also have an opportunity to strengthen our presence in the functional food market in partnership with the world’s largest food company in the rapidly growing and profitable healthcare nutrition segment” said Mr. Henri Harland, president and CEO at Neptune.

“I am very excited about the opportunity to join the Nestlé Research Center Team in investigating new frontiers for Neptune Krill Oil” said Dr. Tina Sampalis, Vice President of R&D; and Business Development.

“Following the trend of tremendous growth witnessed in functional food & drink, we are extremely pleased with our collaboration with Nestlé. Moreover, in order to further capitalize on the sustainable growth of the functional food market as planned in our business plan, we are already targeting more strategic worldwide partners” said Mr. Thierry Houillon, Vice President of Business Development, Functional food at Neptune.

About Nestlé and Nestlé Research Center
Nestlé with headquarters in Vevey, Switzerland was founded in 1866 by Henri Nestlé and is today the world's biggest food and beverage company. Sales for 2006 were CHF 98.5 bn, with a net profit of CHF 9 bn.

Established in 1987, the Nestlé Research Center (NRC), Lausanne, Switzerland, is one of the world’s leading research institutions in food, nutrition and life sciences. With a diverse staff of leading researchers from a broad range of scientific competencies, NRC possesses a unique blend of talent and expertise. Knowledge on nutrition and health, food science, food/consumer interaction and food quality and safety are combined at the Nestlé Research Center to help develop Good Food as a source of Good Health throughout life.

About Neptune Technologies & Bioressources Inc.: https://www.neptunebiotech.com
Neptune Technologies & Bioressources Inc. develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract™). Using its proprietary process, Neptune Technologies & Bioressources Inc. is strategically positioning itself in the health and wellness market .

Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such as the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.

Neither NASDAQ nor TSX venture exchange accepts responsibility for the adequacy or accuracy of this press release.
Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc.
Acasti Pharma Inc.
Toni Rinow, Ph.D., MBA
Corporate Development & Investor Relations
(450) 687-2262
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
# # #
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission and the Canadian securities commissions.
 

We communicate

NTB (TSX) CAN$ 1.93 +0.03
NEPT (NASDAQ) US$ 1.898 +0.068
 

press releases

Investor Relations Contact NEPTUNE TECHNOLOGIES & BIORESSOURCES